Cipher Pharmaceuticals Inc.
CPH
Rank in Stocks
#15715
Cipher Pharmaceuticals Inc., founded in 2000 and based in Oakville, Canada,... Cipher Pharmaceuticals Inc., founded in 2000 and based in Oakville, Canada, operates as a specialized pharmaceutical enterprise. The company markets a diverse portfolio of commercial therapeutic solutions. These include Epuris (CIP-ISOTRETINOIN), formulated for severe acne; Ozenoxacin, targeting impetigo in both adult and pediatric patients; Actikerall, prescribed for palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a topical cream designed to mitigate unwanted facial hair growth in women; BRINAVESS, utilized for restoring sinus rhythm in adults; and AGGRASTAT, an intravenous anti-platelet medication. Beyond its directly marketed offerings, Cipher's portfolio encompasses various licensed products, such as CIP-Isotretinoin; Lipofen (CIP-Fenofibrate), used in the management of hyperlipidemia, a lipid metabolism disorder; and Conzip/Durela (CIP-Tramadol), indicated for the relief of moderate to moderately severe pain. Looking to the future, Cipher maintains a robust developmental pipeline, which includes Trevyent, a vasodilatory prostacyclin analogue aimed at treating pulmonary arterial hypertension; CF-101, under investigation for severe plaque psoriasis and rheumatoid arthritis; MOB-015, a topical terbinafine formulation for onychomycosis; and DTR-001, a novel cream for tattoo removal.
Share Price
$9.74
Last synced: 2026-11-09
Market Cap
$247.47M
Change (1 day)
1.78%
Change (1 year)
0.45%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Cipher Pharmaceuticals Inc. (CPH)
Category
Healthcare
Operating Margin for Cipher Pharmaceuticals Inc. (CPH)
Operating Margin as of November 2026 TTM: 38.75%
According to Cipher Pharmaceuticals Inc.'s latest financial reports, its current operating margin (TTM) is 38.75%. At the end of 2025 the company had an operating margin of 32.73%.
Operating Margin history for Cipher Pharmaceuticals Inc. from 2004 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 38.75% | 18.39% |
| 2025 | 32.73% | 39.16% |
| 2024 | 23.52% | -56.83% |
| 2023 | 54.48% | -6.44% |
| 2022 | 58.23% | 8.09% |
| 2021 | 53.87% | -4.55% |
| 2020 | 56.44% | 8.48% |
| 2019 | 52.03% | 122.07% |
| 2018 | 23.43% | -62.57% |
| 2017 | 62.60% | -180.12% |
| 2016 | -78.13% | 38,965.00% |
| 2015 | -0.20% | -99.66% |
| 2014 | -58.44% | -186.94% |
| 2013 | 67.22% | 137.95% |
| 2012 | 28.25% | -142.01% |
| 2011 | -67.25% | 35,294.74% |
| 2010 | -0.19% | -99.79% |
| 2009 | -89.30% | -64.32% |
| 2008 | -250.29% | -81.45% |
| 2007 | -1,349.07% | 1.55% |
| 2006 | -1,328.53% | -39.50% |
| 2005 | -2,196.01% | 9,185.45% |
| 2004 | -23.65% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -99.50% |
DE
|
|
| 19.68% | -99.49% |
DE
|
|
| 13.26% | -99.66% |
JP
|
|
| 17.08% | -99.56% |
CH
|
|
| 14.92% | -99.61% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Cipher Pharmaceuticals Inc.'s operating margin
What is Cipher Pharmaceuticals Inc.'s operating margin?
Cipher Pharmaceuticals Inc.'s operating margin is 38.75%, as of Nov 2026.
What was Cipher Pharmaceuticals Inc.'s operating margin in 2025?
In 2025, Cipher Pharmaceuticals Inc.'s operating margin was 32.73%, compared with 23.52% in 2024.
How has Cipher Pharmaceuticals Inc.'s operating margin changed since 2020?
From 2020 to 2025, Cipher Pharmaceuticals Inc.'s operating margin was highest in 2022 (58.23%) and lowest in 2024 (23.52%).
How does Cipher Pharmaceuticals Inc.'s operating margin compare with similar companies?
Cipher Pharmaceuticals Inc.'s operating margin (38.75%) is higher than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.